Schedule 13G ownership disclosure

CELLECT BIOTECHNOLOGY LTD

Security class unavailable · CUSIP: 15116C102

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,000,000
Percent of class
1.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000013
Form type
SC 13G/A
Filer
Quoin Pharmaceuticals, Ltd.
CIK
CIK 1671502
Filed
Jan 03, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub